Seminars in Cancer Biology

Papers
(The H4-Index of Seminars in Cancer Biology is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ferroptosis is a type of autophagy-dependent cell death625
Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy323
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges237
The role of SOX family members in solid tumours and metastasis229
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer224
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy220
SOX2 in development and cancer biology202
Radiomics in breast cancer classification and prediction198
Targeting p53 for the treatment of cancer185
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond183
The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics180
RAF-MEK-ERK pathway in cancer evolution and treatment166
Curcumin and colorectal cancer: An update and current perspective on this natural medicine154
lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions148
Artificial intelligence for breast cancer detection in mammography and digital breast tomosynthesis: State of the art147
Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives147
Pathology of triple negative breast cancer145
Machine and deep learning approaches for cancer drug repurposing140
An update on vitamin D signaling and cancer138
Regulation of autophagy by canonical and non-canonical ER stress responses137
Dietary fat, bile acid metabolism and colorectal cancer131
SOX4: The unappreciated oncogene131
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC128
Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects127
An updated overview on metal nanoparticles toxicity120
The complexity of p53-mediated metabolic regulation in tumor suppression120
Regulation and function of SOX9 during cartilage development and regeneration115
The impact of VEGF on cancer metastasis and systemic disease115
Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer114
Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges112
Epigenetics in hepatocellular carcinoma108
Precision medicine in non-small cell lung cancer: Current applications and future directions107
PROTACs: A novel strategy for cancer therapy107
DNMT1: A key drug target in triple-negative breast cancer105
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics104
The oral microbiota and its role in carcinogenesis103
EGFR signaling pathway as therapeutic target in human cancers102
Applications and strategies in nanodiagnosis and nanotherapy in lung cancer101
Artificial intelligence aids in development of nanomedicines for cancer management101
Tumor glycolysis, an essential sweet tooth of tumor cells99
The Skp2 Pathway: A Critical Target for Cancer Therapy99
Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches98
TGF-β in developmental and fibrogenic EMTs97
Neutrophil extracellular traps in cancer97
Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics96
RNA methylations in human cancers95
Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement92
Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers91
Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer91
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds89
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies88
Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities87
Drug repurposing for breast cancer therapy: Old weapon for new battle86
Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics86
Anticancer potential of garlic and its bioactive constituents: A systematic and comprehensive review85
Epidemiology of breast cancer, a paradigm of the “common soil” hypothesis84
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy81
Colorectal cancer occurrence and treatment based on changes in intestinal flora80
Ginger and its active compounds in cancer therapy: From folk uses to nano-therapeutic applications79
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives78
Hedgehog signaling mechanism and role in cancer78
Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology77
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine77
Recent insight into the role of FBXW7 as a tumor suppressor77
Dissenting degradation: Deubiquitinases in cell cycle and cancer76
NEDD4 E3 ligase: Functions and mechanism in human cancer75
Mechanisms of cancer metastasis75
Circular RNAs in cancer: Limitations in functional studies and diagnostic potential75
AMPK signaling and its targeting in cancer progression and treatment74
Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature74
SOX4: Epigenetic regulation and role in tumorigenesis74
Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications73
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress73
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments73
Role of iron in cancer73
0.057873010635376